Showing results (21-30 of 339) with videos related to
Sort By:
Pageof 34
Frontiers in Oncology|July 2, 2019
Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and TherapyIsabel Heidegger, Andreas Pircher, Renate PichlerTranslational Lung Cancer Research|March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug developmentWolfgang Hilbe, Christian Manegold, Andreas PircherCurrent Opinion in Urology|August 21, 2023
Pembrolizumab in mCRPC - Combination therapies as breakthrough to success?Stefan Plas, Andreas Pircher, Isabel HeideggerRNA Biology|February 19, 2015
Ribosome-associated ncRNAs: an emerging class of translation regulatorsAndreas Pircher, Jennifer Gebetsberger, Norbert PolacekWorld Journal of Hepatology|March 23, 2011
Liver cancer: Targeted future optionsAndreas Pircher, Michael Medinger, Joachim DrevsLung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.Onkologie|May 18, 2011
Cancer stem cells: characteristics and their potential role for new therapeutic strategiesStephan R Bohl, Andreas Pircher, Wolfgang HilbeHeliyon|May 1, 2024
Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissuesStefan Salcher, Isabel Heidegger, Gerold Untergasser, et al.Expert Review of Hematology|April 19, 2011
Dose escalation of imatinib in chronic-phase chronic myeloid leukemia patients: is it still reasonable?Jakob Rudzki, Dominik WolfCancer Immunology Research|April 1, 2022
IFNγ Helps CBLB-Deficient CD8+ T Cells to Put Up Resistance to TregsDominik Wolf, Gottfried BaierPageof 34